A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
This project report is submitted in partial fulfilment of the requirements for the degree of Bachelor of Pharmacy, 2018.
Autor principal: | Haque, Mushfiqul |
---|---|
Altres autors: | Kabir, Md. Tanvir |
Format: | Project report |
Idioma: | English |
Publicat: |
BRAC University
2019
|
Matèries: | |
Accés en línia: | http://hdl.handle.net/10361/11070 |
Ítems similars
-
Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
per: Ishrat, Nowshin
Publicat: (2024) -
Anti-alzheimer and antioxidant activity of celastrus paniculatus seed
per: Alam, Badrul, et al.
Publicat: (2016) -
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
per: Flora, Sanzida Alam
Publicat: (2024) -
A review on artemisinin based combination therapy for the treatment of Malaria
per: Chowdhury, Amina Ferdous
Publicat: (2020) -
Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
per: Alim, Abdul
Publicat: (2023)